Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN- γ Signaling.

CONCLUSION: PMQ could inhibit HCC progression in obese mice at least in part through down-regulating adipocytes-induced PD-L1 expression via IFN-γ signaling.
PMID: 32748749 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - July 29, 2020 Category: Cancer & Oncology Authors: Li Z, Gao WQ, Wang P, Wang TQ, Xu WC, Zhu XY, Liu H Tags: Curr Cancer Drug Targets Source Type: research